[痴呆症与生活方式疾病的关系]。

Q4 Medicine
Ryosuke Shimasaki, Masanori Kurihara, Atsushi Iwata
{"title":"[痴呆症与生活方式疾病的关系]。","authors":"Ryosuke Shimasaki, Masanori Kurihara, Atsushi Iwata","doi":"10.11477/mf.1436205028","DOIUrl":null,"url":null,"abstract":"<p><p>As society ages, the number of people with dementia increases worldwide, and the prevention of dementia has become increasingly important. Lifestyle diseases are associated with the development of dementia, and preventing or controlling lifestyle diseases in middle-aged individuals is particularly important. Hypertension, diabetes, and dyslipidemia are associated with dementia. Hypertension is strongly associated with dementia, and strict blood pressure control is required. Among the drugs used to treat lifestyle diseases, some antihypertensive drugs(e.g., dihydropyridine calcium channel blockers, angiotensin 2 receptor blockers), hypoglycemic drugs(e.g., glucagon-like peptide 1 receptor agonists and sodium-glucose co-transporter-2 inhibitors), and statins may reduce the incidence of dementia. However, individual interventions for lifestyle diseases have only a limited effect in reducing the incidence of dementia. Comprehensive interventions may have significant effects. Clinicians involved in the management of lifestyle diseases need to have sound knowledge of these diseases and provide comprehensive management at an early stage.</p>","PeriodicalId":35984,"journal":{"name":"Neurological Surgery","volume":"52 6","pages":"1113-1122"},"PeriodicalIF":0.0000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Relationship Between Dementia and Lifestyle Diseases].\",\"authors\":\"Ryosuke Shimasaki, Masanori Kurihara, Atsushi Iwata\",\"doi\":\"10.11477/mf.1436205028\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>As society ages, the number of people with dementia increases worldwide, and the prevention of dementia has become increasingly important. Lifestyle diseases are associated with the development of dementia, and preventing or controlling lifestyle diseases in middle-aged individuals is particularly important. Hypertension, diabetes, and dyslipidemia are associated with dementia. Hypertension is strongly associated with dementia, and strict blood pressure control is required. Among the drugs used to treat lifestyle diseases, some antihypertensive drugs(e.g., dihydropyridine calcium channel blockers, angiotensin 2 receptor blockers), hypoglycemic drugs(e.g., glucagon-like peptide 1 receptor agonists and sodium-glucose co-transporter-2 inhibitors), and statins may reduce the incidence of dementia. However, individual interventions for lifestyle diseases have only a limited effect in reducing the incidence of dementia. Comprehensive interventions may have significant effects. Clinicians involved in the management of lifestyle diseases need to have sound knowledge of these diseases and provide comprehensive management at an early stage.</p>\",\"PeriodicalId\":35984,\"journal\":{\"name\":\"Neurological Surgery\",\"volume\":\"52 6\",\"pages\":\"1113-1122\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Neurological Surgery\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.11477/mf.1436205028\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neurological Surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.11477/mf.1436205028","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

摘要

随着社会老龄化,世界范围内痴呆症患者人数增加,预防痴呆症变得越来越重要。生活方式疾病与痴呆症的发展有关,预防或控制中年人的生活方式疾病尤为重要。高血压、糖尿病和血脂异常与痴呆有关。高血压与痴呆密切相关,需要严格控制血压。在治疗生活方式疾病的药物中,一些降压药(如:,二氢吡啶钙通道阻滞剂,血管紧张素2受体阻滞剂),降糖药物(如。(胰高血糖素样肽1受体激动剂和钠-葡萄糖共转运蛋白2抑制剂)和他汀类药物可能降低痴呆的发病率。然而,针对生活方式疾病的个人干预措施在减少痴呆症发病率方面的效果有限。综合干预可能有显著效果。参与生活方式疾病管理的临床医生需要对这些疾病有充分的了解,并在早期阶段提供全面的管理。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
[Relationship Between Dementia and Lifestyle Diseases].

As society ages, the number of people with dementia increases worldwide, and the prevention of dementia has become increasingly important. Lifestyle diseases are associated with the development of dementia, and preventing or controlling lifestyle diseases in middle-aged individuals is particularly important. Hypertension, diabetes, and dyslipidemia are associated with dementia. Hypertension is strongly associated with dementia, and strict blood pressure control is required. Among the drugs used to treat lifestyle diseases, some antihypertensive drugs(e.g., dihydropyridine calcium channel blockers, angiotensin 2 receptor blockers), hypoglycemic drugs(e.g., glucagon-like peptide 1 receptor agonists and sodium-glucose co-transporter-2 inhibitors), and statins may reduce the incidence of dementia. However, individual interventions for lifestyle diseases have only a limited effect in reducing the incidence of dementia. Comprehensive interventions may have significant effects. Clinicians involved in the management of lifestyle diseases need to have sound knowledge of these diseases and provide comprehensive management at an early stage.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Neurological Surgery
Neurological Surgery Medicine-Medicine (all)
自引率
0.00%
发文量
99
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信